A View LCS vs eMurmur Heart AI
AI Verdict
Choose AVIEW LCS if…
Choose A View LCS if your primary need is comprehensive, AI-powered analysis of thoracic CT scans for conditions like lung cancer, emphysema, and coronary artery disease. This tool is ideal for radiology departments and pulmonology practices requiring automated nodule detection, Lung-RADS scoring, and detailed quantification of lung and cardiac pathologies from imaging data.
View AVIEW LCS →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an AI-powered solution for automated analysis of heart and lung sounds, especially for screening and monitoring cardiac murmurs and respiratory anomalies. This platform is best suited for clinicians seeking to enhance auscultation capabilities at the point of care or in telehealth settings, providing hemodynamic insights and supporting remote consultations.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Pricing | Subscription or one-off payment | Contact for quote |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers broad accessibility through its mobile app and web application, supporting diverse clinical settings and telehealth workflows. Its emphasis on a simple, proven UI and hardware-agnostic compatibility makes it highly adaptable for various users and environments. A View LCS, while offering flexible deployment and mobile viewing, is more specialized for imaging specialists and their workflows.
Clinical Value
AVIEW LCSA View LCS provides comprehensive, quantitative analysis for multiple serious thoracic conditions (lung cancer, emphysema, coronary artery disease) from a single low-dose CT scan, with studies showing it can reduce misclassification compared to human radiologists. eMurmur Heart AI significantly enhances traditional auscultation with high accuracy for murmur detection and hemodynamic insights, but Tool A's multi-disease diagnostic utility from one imaging modality offers a broader clinical impact.
Pricing & Value
eMurmur Heart AIBoth tools require direct contact for pricing, making a detailed value comparison challenging. However, eMurmur Heart AI offers a free 30-day trial, allowing potential users to evaluate its functionality and fit within their practice before committing financially. This transparency in offering a trial period provides a slight advantage in perceived value.
Enterprise Readiness
AVIEW LCSBoth tools are FDA-cleared, HIPAA compliant, and offer BAA, demonstrating strong regulatory readiness. A View LCS offers a wider range of deployment options, including cloud, hybrid, local dedicated hardware, and virtualized solutions, providing greater flexibility for integration into diverse and complex enterprise IT infrastructures. Its extensive DICOM output and PACS/RIS/CIS integration further enhance its enterprise compatibility.
Innovation
AVIEW LCSA View LCS demonstrates significant innovation by providing integrated, fully automatic analysis for lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. Its unique 'CT kernel conversion AI technology' further addresses a critical challenge in standardizing image input. While eMurmur Heart AI's AI-powered, hardware-agnostic auscultation for telehealth is also innovative, Tool A's multi-disease, multi-organ assessment from a single acquisition represents a more complex and impactful technical advancement in imaging diagnostics.
Support & Docs
eMurmur Heart AINeither tool provides extensive public details on dedicated support channels or comprehensive documentation. However, eMurmur Heart AI offers e-consultation services, 24/7 web-based access to stored data, and a free trial, suggesting a more accessible and proactive approach to user support and engagement. A View LCS mentions 'support documentation' but lacks specific details on its accessibility or scope.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Name | A View LCS | eMurmur Heart AI |
| Company | Coreline Soft | eMurmur |
| Description | AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| GDPR Compliant | yes | yes |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Internal Medicine, Pulmonology |
| Key Features | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA), Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries, Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole), Mobile app (iOS, Android) and web portal for access, Hardware-neutral and stethoscope agnostic platform compatibility, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring |
| Founded Year | 2012 | 2014 |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and eMurmur Heart AI.